Dawaa Reference

Clinical reference

Blood cancer (unspecified type)

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources3 sources

Febrile Neutropenia - StatPearls - NCBI Bookshelf (NBK541102) - https://www.ncbi.nlm.nih.gov/books/NBK541102/ · ICPC-3 (WONCA International Classification of Primary Care, 3rd edition) class BD25 - condition scope only, no dose · No dose - referral pathway, no medicine given in primary care

Verified against1 document
  • No dose - referral pathway, no medicine given in primary care

Verified date2026-08

1

NO DRUG THERAPY IN PRIMARY CARE (REFERRAL & ADVICE)

1st line
Adult dose and duration

An umbrella category for suspected blood cancer before a specific type is known (see separate leukaemia, lymphoma, and myeloma entries); GP's role is urgent haematology/oncology referral plus symptomatic care (e.g. analgesia) while awaiting it. - Refer, with advice

Paediatric dose

Children follow the same pathway: recognise and refer. No primary-care medicine is implied.

Dose source

No dose - referral pathway, no medicine given in primary care

Why

An umbrella category for suspected blood cancer before a specific type is known (see separate leukaemia, lymphoma, and myeloma entries); GP's role is urgent haematology/oncology referral plus symptomatic care (e.g. analgesia) while awaiting it.

Cautions
  • No medicine is prescribed for this in primary care - this entry is for recognition and referral. Anything given is decided by the service it is referred to.
  • RED FLAG - Unexplained bruising or bleeding, persistent fever, night sweats or weight loss (B symptoms), marked pallor or fatigue, unexplained lymphadenopathy or bone pain, or recurrent infections.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.